Content about Expectorants

March 18, 2013
Perrigo launches store-brand guaifenesin 600-mg extended-release tablets

Perrigo announced that it has begun shipments of guaifenesin 600-mg extended-release tablets. It's the first product that is generically equivalent to Reckitt Benckiser's Mucinex 600-mg extended-release tablets.

ALLEGAN, Mich. — Perrigo on Monday announced that it has begun shipments of guaifenesin 600-mg extended-release tablets. It's the first product that is generically equivalent to Reckitt Benckiser's Mucinex 600-mg extended-release tablets. 

April 12, 2012
Perrigo to launch store-brand Mucinex equivalent

Perrigo on Thursday announced that it has initiated shipments of its guaifenesin extended-release tablets in the 600-mg strength, a generic version of Mucinex.

ALLEGAN, Mich. — Perrigo on Thursday announced that it has initiated shipments of its guaifenesin extended-release tablets in the 600-mg strength, a generic version of Mucinex.

The company expects to initiate its full-scale over-the-counter launch of the store-brand equivalent to Mucinex in blister packaging to its retail and wholesale customers before the end of its current fiscal year in June.

Mucinex 600-mg tablets has estimated annual sales of approximately $135 million, according to Perrigo.

January 25, 2012
Help Remedies introduces guaifenesin SKU

Help Remedies last week launched a new product targeted toward those suffering from chest congestion.

NEW YORK — Help Remedies last week launched a new product targeted toward those suffering from chest congestion. The new expectorant, branded "Help I have chest congestion," contains the single active ingredient guaifenesin (200 mg), and is now available nationally at Target, the company stated.

November 4, 2011
Getting some ‘Help’

A consumer’s internal alarm bell usually is tripped when a company tries to sell him or her on a “less-is-more” proposition, because it usually really means “less-is-less.” That is until Help Remedies came along with its “less-is-less-but-that’s-better” proposition.


NEW YORK — A consumer’s internal alarm bell usually is tripped when a company tries to sell him or her on a “less-is-more” proposition, because it usually really means “less-is-less.” That is until Help Remedies came along with its “less-is-less-but-that’s-better” proposition.


It’s a minimalist movement of single-ingredient OTCs — less drugs, less dyes, less coatings and less confusion because all products are named “Help I have ...” followed by the one symptom treated.


February 10, 2011
Court: Watson's generic OTC decongestant does not infringe on branded versions

Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

MORRISTOWN, N.J. — Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

December 20, 2009
Survey: Adults have trouble picking appropriate treatments for cough symptoms

Consumers can be expected to self-identify a cough, and even locate a cough remedy in...

NEW YORK Consumers can be expected to self-identify a cough, and even locate a cough remedy in the nonprescription aisles. But consumers cannot be expected to distinguish between dextromethorphan and guaifenesin necessarily. Both are indicated for cough relief, but work in entirely different ways. For that you need a readily accessible healthcare professional, such as the pharmacist or nurse practitioner.